维生素D3作为多发性硬化症的附加治疗:随机对照试验的系统审查和元分析
João Vitor Mahler1, Marina Solti1, Samira Luísa Apóstolos-Pereira2
1School of Medicine, University of São Paulo, São Paulo, Brazil.
Multiple sclerosis and related disorders
|January 11, 2024
概括
高剂量的维生素D3补充剂并没有显著改善多发性硬化症 (MS) 患者的临床结果. 虽然在这个元分析中没有减少新的T2病变,但需要进一步的研究来探索潜在的长期益处.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 营养科学 营养科学
背景情况:
- 维生素D缺乏与增加多发性硬化症 (MS) 风险和进展有关.
- 维生素D3作为MS的辅助疗法的作用受到争议.
- 这项研究研究了高剂量维生素D3补充剂在MS管理中的作用.
结论:
- 目前的证据表明,维生素D3补充剂不会显著影响MS的临床结果.
- 减少新的T2病变的非显著趋势需要进一步调查.
- 需要额外的研究来验证潜在的长期益处.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195